Biobanking for NEC: Challenges & Opportunities Misty Good, MD, - - PowerPoint PPT Presentation

biobanking for nec
SMART_READER_LITE
LIVE PREVIEW

Biobanking for NEC: Challenges & Opportunities Misty Good, MD, - - PowerPoint PPT Presentation

Biobanking for NEC: Challenges & Opportunities Misty Good, MD, MS Division of Newborn Medicine Department of Pediatrics Washington University School of Medicine Image source: L. Rubenstein/Broad Institute Audience Poll Raise your


slide-1
SLIDE 1

Biobanking for NEC: Challenges & Opportunities

Misty Good, MD, MS Division of Newborn Medicine Department of Pediatrics Washington University School of Medicine

Image source: L. Rubenstein/Broad Institute

slide-2
SLIDE 2

Audience Poll

  • Raise your hand if your center collects

samples from babies with NEC?

Image source: Susies Heart Photography

slide-3
SLIDE 3

Objectives

  • Discuss the purpose of the biorepository
  • Define samples interested in collecting
  • Discuss infrastructure for biorepository
  • Review database capabilities
  • Discuss specimen procurement
  • Review funding opportunities
  • Discussion

Image source: UC Davis Health

slide-4
SLIDE 4

Biorepository

  • Definition: Biologic materials repository that

collects, processes, stores and distributes biospecimens to support future scientific investigation.

  • Purpose: To maintain biological specimens and

associated info for future use.

  • Biorepository assures the quality and manages

the accessibility and distribution of the samples.

Image source: Pediatric Research Alliance

slide-5
SLIDE 5

NEC Biorepository

  • NEC Society Meeting UC Davis April 2017
  • Focus group convened to discuss interest,

challenges, and opportunities

  • This group has a shared vision to advance

the state of the science to combat NEC

Image source: Univ of Chicago Science Life

slide-6
SLIDE 6

Biorepository Aims

  • Aim 1: Develop and maintain a NEC

specimen biorepository with linked clinical metadata accessible to investigators across multiple institutions within/outside the US.

  • Aim 2: Develop and maintain the

infrastructure to execute large observational studies utilizing NEC specimens across multiple institutions within/outside the US.

slide-7
SLIDE 7

Biorepository Aims

  • Overarching goal: To promote, facilitate,

and accelerate basic and clinical- translational observational studies of NEC in humans.

Image source: EPL Archives Biorepository

slide-8
SLIDE 8

Who is involved?

  • A team of investigators dedicated to

advancing the field of NEC research.

  • Several investigators from the NEC

Society Research Collaborative.

Image source: Pediatric Research Alliance

slide-9
SLIDE 9

What are centers currently collecting?

  • Several centers currently collecting:

– Intestine – Stool

  • To a lesser extent:

– Blood – Urine

  • Rarely:

– Gastric aspirates – Saliva – Maternal breast milk

Image source: petpookiddos.com

slide-10
SLIDE 10

What are we interested in collecting?

  • Blood, stool, and intestine
  • Intestine only
  • Blood and stool
  • Stool and intestine
  • All the bodily fluids listed on previous slide

Image source: MUSC

slide-11
SLIDE 11

What are we interested in collecting?

  • All the bodily fluids listed on previous

slide

Image source: MUSC

slide-12
SLIDE 12

Infrastructure

  • IRB approvals, standardized informed

consents and protocols

  • Research coordinator and/or staff for

consenting

  • Surgeons/pathologists on board
  • Team of tissue collectors with access
  • SOPs: Specimen notification
  • SOPs: Tissue/sample handling

Image source: Gencure.org

slide-13
SLIDE 13

Tissue Procurement

  • Intestinal resections for NEC and “Non-

NEC” tissue from stoma closures, atresias, SIPs, strictures.

  • Detailed procedures for tissue

procurement, processing and storage are required.

slide-14
SLIDE 14

Intestinal Resection SOP

  • Once the resection comes into lab, it is cut up

and banked as below:

– RNA later for gene expression studies stored at -80 – 4% PFA for histology, processed and sectioned – Snap frozen for microbiota 16S stored at -80 – Snap frozen for a backup sample stored at -80 – Snap frozen piece for Repository – Rest is processed fresh for ex vivo studies (i.e. isolating intestinal stem cells, making enteroids, etc.)

slide-15
SLIDE 15

Other Specimens

  • Blood
  • Urine
  • Stool
  • Gastric or tracheal aspirates
  • Breast milk
  • Saliva

– All stored in -80

Image source: ITOR Biorepository

slide-16
SLIDE 16

Infrastructure

  • Equipment: Dedicated freezers with temp

monitoring, centrifuges

  • Consumables: PPE, surgical instruments,

tubes, racks, boxes, RNA later, formalin

  • Training and Compliance: CITI modules,

HIPAA, BBP

  • Archiving system: Database, labeling,

access to PHI

slide-17
SLIDE 17

Infrastructure

  • Archiving system: Barcoding system for

ease of locating and specimen retrieval

  • Freezers: Secure with alarms and

procedures in place for loss of electrical power, minimize access

Image source: L. Rubenstein/Broad Institute Image source: L. Biologix

slide-18
SLIDE 18

Infrastructure

  • Strict case definitions: Review by site

PIs and research coordinators

  • Consenting: Standardized, rapid
  • Recent scrutiny surrounding saving samples
  • No consent: If parents unavailable, ability

to acquire NEC tissue fresh or stool until parents are available within 24 hrs

slide-19
SLIDE 19

How do we start?

  • Setting up the infrastructure.
  • Multi-center IRBs for the virtual

biorepository, database and sharing of samples/information between centers.

Image source: Sterling IRB

slide-20
SLIDE 20

Database

  • Using REDCap database for clinical

information since it’s free and accessible everywhere.

Image source: MiFID II

slide-21
SLIDE 21

What is REDCap?

  • Research Electronic Data Capture
  • A secure web application designed to support

data capture for research studies.

  • REDCap allows users to build and manage
  • nline databases quickly and securely.
  • Developed at Vanderbilt University; used by

>2000 institutions.

  • Many centers are already using it and their

CTSIs provide support on REDCap.

slide-22
SLIDE 22

REDCap

  • For more information on REDCap:

http://project-redcap.org/

slide-23
SLIDE 23

Accurate Recordkeeping

  • Finalize clinical parameters

to be obtained

– Birth, feeding, antibiotic, drug, transfusion history

  • Data repository quality

– Timely entering of data after samples obtained

  • International collaborations

Image source: Northwestern

slide-24
SLIDE 24

Material/Data Sharing

  • Investigators from all centers able to

collaborate with the NEC Society Biorepository

– Collaboration with a participating center required

  • Application will be available online through

the NEC Society website

  • Biorepository scientific advisory board will

review applications

slide-25
SLIDE 25

Biorepository Maintenance

  • Funding

– Each center to obtain their own? – Internal, NIH, Foundations, PCORI

  • Protection of confidentiality

across all centers

– Anonymous coding – Minimize individuals with access to coding identifiers

Image source: Air Cargo World

slide-26
SLIDE 26

Summary

  • NEC Society investigators are committed

to the development of a national/international biorepository of biological samples from infants afflicted with NEC.

  • Goal is to improve human specimen

studies by individual NEC investigators and foster collaborations across multiple centers.

slide-27
SLIDE 27

Summary

  • It is the hope of all involved in the NEC

Society Biorepository that we can improve, facilitate, and accelerate basic and clinical/translational studies of NEC.

slide-28
SLIDE 28

Acknowledgements

  • NEC Society for bringing all the

investigators together for this amazing collaborative.

  • Jennifer and Dr. Noah Canvasser
slide-29
SLIDE 29

Thank you for your attention! Questions? Interested in being a part

  • f the NEC Society

Biorepository?? Email: mistygood@wustl.edu jennifer@necsociety.org